FR2275215A1 - NEW HETEROCYCLICAL DERIVATIVES OF DESACETOXYCEPHALOSPORIN, PROCESS FOR THEIR PREPARATION AND APPLICATION AS A MEDICINAL PRODUCT - Google Patents
NEW HETEROCYCLICAL DERIVATIVES OF DESACETOXYCEPHALOSPORIN, PROCESS FOR THEIR PREPARATION AND APPLICATION AS A MEDICINAL PRODUCTInfo
- Publication number
- FR2275215A1 FR2275215A1 FR7519213A FR7519213A FR2275215A1 FR 2275215 A1 FR2275215 A1 FR 2275215A1 FR 7519213 A FR7519213 A FR 7519213A FR 7519213 A FR7519213 A FR 7519213A FR 2275215 A1 FR2275215 A1 FR 2275215A1
- Authority
- FR
- France
- Prior art keywords
- desacetoxycephalosporin
- heterocyclical
- derivatives
- preparation
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH853774A CH609989A5 (en) | 1974-06-21 | 1974-06-21 | Process for the preparation of acyl derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2275215A1 true FR2275215A1 (en) | 1976-01-16 |
FR2275215B1 FR2275215B1 (en) | 1980-05-16 |
Family
ID=4341690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7519213A Granted FR2275215A1 (en) | 1974-06-21 | 1975-06-19 | NEW HETEROCYCLICAL DERIVATIVES OF DESACETOXYCEPHALOSPORIN, PROCESS FOR THEIR PREPARATION AND APPLICATION AS A MEDICINAL PRODUCT |
Country Status (25)
Country | Link |
---|---|
JP (1) | JPS625917B2 (en) |
AT (1) | AT337897B (en) |
AU (1) | AU498387B2 (en) |
BE (1) | BE830455A (en) |
BR (1) | BR7503782A (en) |
CA (1) | CA1111021A (en) |
CH (1) | CH609989A5 (en) |
CU (1) | CU34293A (en) |
DD (1) | DD121113A5 (en) |
DE (1) | DE2527291A1 (en) |
DK (2) | DK153155C (en) |
FI (1) | FI751815A (en) |
FR (1) | FR2275215A1 (en) |
GB (1) | GB1471804A (en) |
HU (1) | HU170576B (en) |
IE (1) | IE41888B1 (en) |
IL (1) | IL47299A (en) |
LU (1) | LU72771A1 (en) |
NL (1) | NL180665C (en) |
NO (1) | NO752202L (en) |
NZ (1) | NZ177508A (en) |
PH (1) | PH13030A (en) |
SE (1) | SE431755B (en) |
SU (2) | SU635873A3 (en) |
ZA (1) | ZA753086B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0000005A1 (en) * | 1977-06-03 | 1978-12-20 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | New cephalosporin derivatives, their preparations and their pharmaceutical compositions |
FR2474030A1 (en) * | 1980-01-17 | 1981-07-24 | Rhone Poulenc Ind | 2-Mercapto-1,2,4-triazine, 1,3,4-triazole or tetrazole derivs. - useful as intermediates for antibacterial cephalosporin(s) |
EP0045525A2 (en) * | 1978-05-30 | 1982-02-10 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Cephalosporin derivatives and process for their preparation |
FR2494278A1 (en) * | 1980-11-20 | 1982-05-21 | Rhone Poulenc Ind | NEW DERIVATIVES OF CEPHALOSPORIN, THEIR PREPARATIONS AND THE MEDICINAL PRODUCTS CONTAINING THEM |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5419990A (en) * | 1977-07-14 | 1979-02-15 | Shionogi & Co Ltd | Dihydrotriazinylthioxacephalosporin |
JP2004538265A (en) * | 2001-04-19 | 2004-12-24 | ビオフェルマ ムルシア,エス.アー. | Method for producing 3-cephalosporanic acid derivative using α-keto acid derivative |
CN101945858B (en) | 2008-03-05 | 2014-05-21 | 默克专利有限公司 | Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3868369A (en) * | 1972-11-14 | 1975-02-25 | Smithkline Corp | 3-heterocyclicthiomethylcephalosporins |
-
1974
- 1974-06-21 CH CH853774A patent/CH609989A5/en not_active IP Right Cessation
-
1975
- 1975-05-13 NZ NZ177508A patent/NZ177508A/en unknown
- 1975-05-13 ZA ZA00753086A patent/ZA753086B/en unknown
- 1975-05-14 IL IL47299A patent/IL47299A/en unknown
- 1975-06-06 AU AU81912/75A patent/AU498387B2/en not_active Expired
- 1975-06-16 SE SE7506908A patent/SE431755B/en not_active IP Right Cessation
- 1975-06-17 PH PH17273A patent/PH13030A/en unknown
- 1975-06-17 DK DK271975A patent/DK153155C/en not_active IP Right Cessation
- 1975-06-17 BR BR4864/75D patent/BR7503782A/en unknown
- 1975-06-18 JP JP50074251A patent/JPS625917B2/ja not_active Expired
- 1975-06-18 FI FI751815A patent/FI751815A/fi not_active Application Discontinuation
- 1975-06-18 SU SU752145554A patent/SU635873A3/en active
- 1975-06-18 IE IE1366/75A patent/IE41888B1/en unknown
- 1975-06-19 DE DE19752527291 patent/DE2527291A1/en active Granted
- 1975-06-19 LU LU72771A patent/LU72771A1/xx unknown
- 1975-06-19 FR FR7519213A patent/FR2275215A1/en active Granted
- 1975-06-20 CA CA229,803A patent/CA1111021A/en not_active Expired
- 1975-06-20 HU HUHO1808A patent/HU170576B/hu unknown
- 1975-06-20 BE BE157517A patent/BE830455A/en not_active IP Right Cessation
- 1975-06-20 CU CU7534293A patent/CU34293A/en unknown
- 1975-06-20 NL NLAANVRAGE7507390,A patent/NL180665C/en not_active IP Right Cessation
- 1975-06-20 NO NO752202A patent/NO752202L/no unknown
- 1975-06-20 GB GB2634175A patent/GB1471804A/en not_active Expired
- 1975-06-20 DD DD186797A patent/DD121113A5/xx unknown
- 1975-06-20 AT AT476975A patent/AT337897B/en not_active IP Right Cessation
-
1976
- 1976-01-07 SU SU762309104A patent/SU589921A3/en active
-
1987
- 1987-08-28 DK DK453687A patent/DK155329C/en not_active IP Right Cessation
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0000005A1 (en) * | 1977-06-03 | 1978-12-20 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | New cephalosporin derivatives, their preparations and their pharmaceutical compositions |
EP0045525A2 (en) * | 1978-05-30 | 1982-02-10 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Cephalosporin derivatives and process for their preparation |
EP0045525A3 (en) * | 1978-05-30 | 1982-02-17 | F. Hoffmann-La Roche & Co. Aktiengesellschaft | Cephalosporin derivatives and process for their preparation |
FR2474030A1 (en) * | 1980-01-17 | 1981-07-24 | Rhone Poulenc Ind | 2-Mercapto-1,2,4-triazine, 1,3,4-triazole or tetrazole derivs. - useful as intermediates for antibacterial cephalosporin(s) |
FR2494278A1 (en) * | 1980-11-20 | 1982-05-21 | Rhone Poulenc Ind | NEW DERIVATIVES OF CEPHALOSPORIN, THEIR PREPARATIONS AND THE MEDICINAL PRODUCTS CONTAINING THEM |
EP0053539A1 (en) * | 1980-11-20 | 1982-06-09 | Rhone-Poulenc Sante | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2323387A1 (en) | NEW QUATERNARY BENZYLATES OF N-ALCOYL-NORTROPINES N-B-SUBSTITUTES, PROCESS FOR THEIR PREPARATION AND MEDICINAL PRODUCT CONTAINING | |
BE833731A (en) | BENZYL ALCOHOL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND APPLICATION AS A MEDICINAL PRODUCT | |
FR2282893A1 (en) | USEFUL THIENOTHIAZINE DERIVATIVES AS MEDICINAL PRODUCTS AND THEIR PREPARATION PROCESS | |
FR2285864A1 (en) | NEW POLYENE DERIVATIVES, THEIR METHOD OF PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
BE845581A (en) | NEW OXAZOLIDINONES- (2), THEIR METHOD OF PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
FR2275215A1 (en) | NEW HETEROCYCLICAL DERIVATIVES OF DESACETOXYCEPHALOSPORIN, PROCESS FOR THEIR PREPARATION AND APPLICATION AS A MEDICINAL PRODUCT | |
FR2292467A1 (en) | NEW DERIVATIVES OF BENZOPHENONE, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS A MEDICINAL PRODUCT | |
FR2289187A1 (en) | NEWS 2- (5- OR 3-PYRAZOLYL) -BENZOPHENONES, THEIR METHOD OF PREPARATION AND THEIR APPLICATION AS A MEDICINAL PRODUCT | |
FR2285870A1 (en) | NEW BENZOFURANE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
BE833807A (en) | PHENOXYALKANECARBONAMIDES OF SUBSTITUTED THIAZOLIDINECARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION AND APPLICATION AS A MEDICINAL PRODUCT | |
FR2294708A1 (en) | NEW 3-FLUORO-2,3-DIHYDRO-1H-1,4-BENZODIAZEPINE-2-ONES, USEFUL AS MEDICINAL PRODUCTS AND THEIR PREPARATION PROCESS | |
FR2321293A1 (en) | NEW 7B- (D-2-AMINO-2- (LOWER ALCOYL-SULFONYLAMINO-PHENYL) - ACETYLAMINO) -3-R-3-CEPHEM-4-CARBOXYLIC ACIDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
FR2292472A1 (en) | NEW ISOINDOLE DERIVATIVES USEFUL AS MEDICINAL PRODUCTS, AND THEIR PREPARATION PROCESS | |
BE831900A (en) | NEW PIPERIDINE DERIVATIVES USEFUL AS MEDICINAL PRODUCTS AND PROCESS FOR THEIR PREPARATION | |
FR2315260A1 (en) | NEW DIHALOGENOUS ARALIPHATIC COMPOUNDS, THEIR APPLICATION AS MEDICINAL PRODUCTS AND THEIR METHOD OF PREPARATION | |
FR2351994A1 (en) | 9- (5-O-ACYL-B-D-ARABINOFURANOSYL) -ADENINIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND APPLICATION AS MEDICINAL PRODUCTS | |
FR2291756A1 (en) | NEW DERIVATIVES OF QUINOXALINE-1,4-DIOXIDE, PROCESS FOR THE PREPARATION OF THESE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM | |
FR2280377A1 (en) | NEW PIPERIDINE DERIVATIVES USEFUL AS MEDICINAL PRODUCTS AND PROCESS FOR THEIR PREPARATION | |
FR2285137A1 (en) | NEW 17-SPIROSULTIN STEROID DERIVATIVES, THE CORRESPONDING G-HYDROXYACIDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS A MEDICINAL PRODUCT | |
BE811560A (en) | THIOPHENE DERIVATIVES, THEIR METHOD OF PREPARATION AND THEIR APPLICATION AS A MEDICINAL PRODUCT | |
FR2276040A1 (en) | NEW DERIVATIVES OF BENZHYDRYLOXY-ALCOYLAMINES, THEIR PROCESS FOR PREPARATION AND MEDICINAL PRODUCTS CONTAINING THESE DERIVATIVES | |
FR2314709A1 (en) | NEW ALCYNIC DERIVATIVES, THEIR METHOD OF PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
FR2330391A1 (en) | NEW DERIVATIVES OF IMIDAZOLE, THEIR APPLICATION AS MEDICINAL PRODUCTS AND THEIR METHOD OF PREPARATION | |
FR2287902A1 (en) | NEW D-HOMOSTEROIDS, THEIR METHOD OF PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
FR2318644A1 (en) | NEW FLUOTEROIDS, THEIR APPLICATION AS MEDICINAL PRODUCTS AND THEIR PREPARATION PROCESS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
ST | Notification of lapse |